Corporate Presentation April 14, 2015 Creating the Next Generation of CNS Drugs Forward-Looking Statement This presentation contains forward-looking statements. These statements relate to future events and involve known - Pimavanserin - Document - PDFSEARCH.IO

First Page	Meta Content
	Corporate Presentation April 14, 2015 Creating the Next Generation of CNS Drugs Forward-Looking Statement This presentation contains forward-looking statements. These statements relate to future events and involve known Add to Reading List Document Date: 2015-04-17 12:22:44 Open Document File Size: 1,76 MB Share Result on Facebook Company ADP / Focused Biopharmaceutical Company / ITT / / Country United States / / Event FDA Phase / / MedicalCondition Chronic disorder / hallucinations / hematological disorder / stroke / cognitive impairment / disease psychosis / Parkinson’s disease psychosis / / Organization FDA / U.S. Securities and Exchange Commission / / Position CGI-S Investigator / CGI-I Investigator / / Product Seroquel / Clozapine / Risperidone / Zyprexa / No drug / PDP / Alzheimer / only drug / HT2A / / Technology CGI / / SocialTag Piperazines Psychiatry Organochlorides Eli Lilly and Company Piperidines Antipsychotic Olanzapine Pimavanserin Psychosis Chemistry

Corporate Presentation April 14, 2015 Creating the Next Generation of CNS Drugs Forward-Looking Statement This presentation contains forward-looking statements. These statements relate to future events and involve knownAdd to Reading List